VIDYA BALKISHUN: Open Payments
NPI 1750432142 · REHOBOTH BEACH, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 9 payments from 6 companies in 2025. Trend: 2023 $143 · 2024 $434 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $242 |
| ABBVIE INC. | 3 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $16 |
Products named: Xofigo, ELAHERE, FRUZAQLA, Fabhalta, Onivyde, NERLYNX, IMBRUVICA.
Industry payments across DE — which companies pay providers there.
